Cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item Thumbnail image Product Price Quantity Subtotal
× Placeholder COVID-19 and Obsessive-Compulsive Disorder: The Nightmare Just Got Real PDF $40.00
$40.00
× Placeholder Electroconvulsive Therapy Device Classification: Response to FDA Advisory Panel Hearing and Recommendations PDF $40.00
$40.00
× Placeholder Suicidal Behavior in Obsessive-Compulsive Disorder PDF $40.00
$40.00
× Placeholder Duloxetine, 60 mg Once Daily, for Major Depressive Disorder: A Randomized Double-Blind Placebo-Controlled Trial PDF $40.00
$40.00
× Placeholder Bioavailability of S-Adenosyl Methionine and Impact on Response in a Randomized, Double-Blind, Placebo-Controlled Trial in Major Depressive Disorder PDF $40.00
$40.00
× Placeholder Exposure to Mirtazapine During Pregnancy: A Prospective, Comparative Study of Birth Outcomes PDF $40.00
$40.00
× Placeholder Comparison of Antidepressant Use Between Subjects With Bipolar Disorder and Major Depressive Disorder With or Without Comorbid Anxiety PDF $40.00
$40.00
× Placeholder Depression Literacy Among Dermatologists: An Online Survey Study in India PDF $40.00
$40.00
× Placeholder Risk of Suicide Attempts Among Adolescents and Young Adults With Autism Spectrum Disorder: A Nationwide Longitudinal Follow-Up Study PDF $40.00
$40.00

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.


Join Now

Cart totals

Subtotal $360.00
Total $360.00
Proceed to checkout

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe